Early mortality in elderly patients undergoing treatment for multiple myeloma in real-world practice.

Xia, Jun; Wang, Lingling; Zhou, Xin; Wang, Jing; Wang, Huan; Guo, Hongfeng

Xia, Jun; Wang, Lingling; Zhou, Xin; Wang, Jing; Wang, Huan; Guo, Hongfeng.

Affiliation

Xia J; Department of Hematology, Wuxi People's Hospital, Nanjing Medical University, Wuxi, China.
Wang L; Department of Hematology, Wuxi People's Hospital, Nanjing Medical University, Wuxi, China.
Zhou X; Department of Hematology, Wuxi People's Hospital, Nanjing Medical University, Wuxi, China.
Wang J; Department of Hematology, Wuxi People's Hospital, Nanjing Medical University, Wuxi, China.
Wang H; Department of Hematology, Wuxi People's Hospital, Nanjing Medical University, Wuxi, China.
Guo H; Department of Hematology, Wuxi People's Hospital, Nanjing Medical University, Wuxi, China.

J Int Med Res ; 46(6): 2230-2237, 2018 Jun.

Article in En | MEDLINE | ID: mdl-29584537

Subject(s)

Multiple Myeloma/mortality; Aged; Aged, 80 and over; Antineoplastic Agents/therapeutic use; Female; Humans; Male; Multiple Myeloma/complications; Multiple Myeloma/drug therapy; Retrospective Studies; Risk Factors; Time Factors

Key words

Elderly; International Staging System; bortezomib; early mortality; lactate dehydrogenase; multiple myeloma

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: J Int Med Res Year: 2018 Document type: Article Affiliation country: China Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google